Healthcare -
Biotechnology - NASDAQ - US
$ 8.83
-2.75 %
$ 517 M
Market Cap
-3.18
P/E
CGEM - CASH & EQUIVALENTS
Cash & Equivalents CGEM - Cullinan Oncology, Inc.
98.4 M
LAST VALUE
-52.20%
2 YEAR CAGR
23.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR